Stock analysis Aarti Drugs Limited AARTIDRUGS
More indepth analysis on MunafaSutra.com
Recent prices of AARTIDRUGS Aarti Drugs Limited are as follows: Daily volume is divided by 10 day averaged volume
Date | Close | Range | Change % | Volume |
03 Thu Jul 2025 | 483.90 | 477.75 to 488.95 | 0.06% | 0.93 times |
02 Wed Jul 2025 | 483.60 | 471.00 to 495.00 | 2.97% | 4.15 times |
01 Tue Jul 2025 | 469.65 | 456.65 to 473.95 | 2.51% | 0.77 times |
30 Mon Jun 2025 | 458.15 | 453.15 to 469.90 | 1.09% | 0.79 times |
27 Fri Jun 2025 | 453.20 | 443.45 to 456.40 | 1.75% | 0.54 times |
26 Thu Jun 2025 | 445.40 | 442.90 to 467.30 | -1.42% | 1.01 times |
25 Wed Jun 2025 | 451.80 | 435.60 to 455.50 | 3.06% | 0.87 times |
24 Tue Jun 2025 | 438.40 | 433.95 to 444.00 | 1.27% | 0.67 times |
23 Mon Jun 2025 | 432.90 | 432.00 to 441.60 | -1.76% | 0.27 times |
20 Fri Jun 2025 | 440.65 | 431.00 to 443.25 | 0.2% | 0.63 times |
19 Thu Jun 2025 | 439.75 | 437.70 to 454.95 | -1.49% | 0.3 times |
18 Wed Jun 2025 | 446.40 | 444.65 to 456.90 | -1% | 0.43 times |
Technical analysis forecast of Aarti Drugs Limited Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Aarti Drugs Limited AARTIDRUGS at this time. Stock is rising and might rise more.
It appears as if Aarti Drugs Limited AARTIDRUGS gave a large move recently.
Stock of Aarti Drugs Limited (AARTIDRUGS) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of Aarti Drugs Limited is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Aarti Drugs Limited stays above 473.2, but if it comes below 473.2, then a intra day sell could be more profitable.
If you take a sell trade below 473.2, then use 473.2 as stoploss and 458.71 as target. However if you take a buy trade in Aarti Drugs Limited, then use 473.2 as stoploss and 490.7 as target.